237 related articles for article (PubMed ID: 27188167)
1. Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature.
Bonfim-Silva R; Souza LE; Melo FU; Oliveira VC; Magalhães DA; Oliveira HF; Covas DT; Fontes AM
Clin Transl Oncol; 2017 Jan; 19(1):125-133. PubMed ID: 27188167
[TBL] [Abstract][Full Text] [Related]
2. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.
Wickersheim A; Kerber M; de Miguel LS; Plate KH; Machein MR
Int J Cancer; 2009 Oct; 125(8):1771-7. PubMed ID: 19582874
[TBL] [Abstract][Full Text] [Related]
3. [Observation on myeloid origin of neovascular endothelial cells and infiltration of bone marrow-originated inflammatory cells in a murine tumor model].
Zhou XS; Gao HX; Yao XJ; Xu SL; Li XY
Ai Zheng; 2008 Aug; 27(8):840-4. PubMed ID: 18710618
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.
Shinde Patil VR; Friedrich EB; Wolley AE; Gerszten RE; Allport JR; Weissleder R
Neoplasia; 2005 Mar; 7(3):234-40. PubMed ID: 15799823
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.
Udagawa T; Puder M; Wood M; Schaefer BC; D'Amato RJ
FASEB J; 2006 Jan; 20(1):95-102. PubMed ID: 16394272
[TBL] [Abstract][Full Text] [Related]
6. IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.
Sorensen EW; Gerber SA; Frelinger JG; Lord EM
J Immunol; 2010 Feb; 184(4):1858-66. PubMed ID: 20061409
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
[TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
[TBL] [Abstract][Full Text] [Related]
9. Involvement of bone marrow-derived vascular progenitor cells in neovascularization during formation of the corpus luteum in mice.
Kizuka F; Tokuda N; Takagi K; Adachi Y; Lee L; Tamura I; Maekawa R; Taketani T; Tamura H; Suzuki T; Owada Y; Sugino N
Biol Reprod; 2012 Sep; 87(3):55. PubMed ID: 22674393
[TBL] [Abstract][Full Text] [Related]
10. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas.
Machein MR; Renninger S; de Lima-Hahn E; Plate KH
Brain Pathol; 2003 Oct; 13(4):582-97. PubMed ID: 14655762
[TBL] [Abstract][Full Text] [Related]
11. Characterization and potential roles of bone marrow-derived stromal cells in cancer development and metastasis.
Kawai H; Tsujigiwa H; Siar CH; Nakano K; Takabatake K; Fujii M; Hamada M; Tamamura R; Nagatsuka H
Int J Med Sci; 2018; 15(12):1406-1414. PubMed ID: 30275769
[No Abstract] [Full Text] [Related]
12. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis.
Amoh Y; Yang M; Li L; Reynoso J; Bouvet M; Moossa AR; Katsuoka K; Hoffman RM
Cancer Res; 2005 Jun; 65(12):5352-7. PubMed ID: 15958583
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived endothelial cells contribute to angiogenesis in murine WEHI and JC tumors.
Stoelting S; Heinze G; Nadrowitz R; Wagner T; Peters SO
Anticancer Res; 2008; 28(2A):771-7. PubMed ID: 18507019
[TBL] [Abstract][Full Text] [Related]
14. The mobilization, recruitment and contribution of bone marrow-derived endothelial progenitor cells to the tumor neovascularization occur at an early stage and throughout the entire process of hepatocellular carcinoma growth.
Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Yu D; Zhou X; Ding Y
Oncol Rep; 2012 Oct; 28(4):1217-24. PubMed ID: 22858892
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain.
Santarelli JG; Udani V; Yung YC; Cheshier S; Wagers A; Brekken RA; Weissman I; Tse V
Neurosurgery; 2006 Aug; 59(2):374-82; discussion 374-82. PubMed ID: 16883178
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of breast tumor growth and abnormal angiogenesis in mice treated with endothelial cells and their progenitor mesenchymal stem cells derived from bone marrow.
Adelipour M; Allameh A; Tavangar SM; Hassan ZM; Soleimani M
Neoplasma; 2016; 63(6):911-924. PubMed ID: 27565329
[TBL] [Abstract][Full Text] [Related]
17. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
18. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
Du W; Takuwa N; Yoshioka K; Okamoto Y; Gonda K; Sugihara K; Fukamizu A; Asano M; Takuwa Y
Cancer Res; 2010 Jan; 70(2):772-81. PubMed ID: 20068174
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.
Davidoff AM; Ng CY; Brown P; Leary MA; Spurbeck WW; Zhou J; Horwitz E; Vanin EF; Nienhuis AW
Clin Cancer Res; 2001 Sep; 7(9):2870-9. PubMed ID: 11555605
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45.
Shaw JP; Basch R; Shamamian P
Blood Cells Mol Dis; 2004; 32(1):168-75. PubMed ID: 14757432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
